SCHEMBL8286371

SCHEMBL8286371

NC(=O)c1nc2c(cc1F)c(=O)cc(Nc1cccc(F)c1)n2-c1cccc(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
RIPK1 Q13546 1/20 0.36
CDK2 P24941 3/20 0.35
CCNA2 P20248 2/20 0.35
ALDH1A2 O94788 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ALDH1A3 P47895 1/20 0.35
MAPT P10636 3/20 0.35
CSF1R P07333 1/20 0.35
CDK4 P11802 1/20 0.34
CCND1 P24385 1/20 0.34
CCND2 P30279 1/20 0.34
CCND3 P30281 1/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
CCNA1 P78396 1/20 0.34
MAPK8 P45983 1/20 0.34
MAPK10 P53779 1/20 0.34
KDM4E B2RXH2 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5871780 0.88 PDE11A (0.41) RIPK1CDK2CCNA2ALDH1A2ALDH1A1
SCHEMBL8287147 0.85 HTT (0.44) RIPK1ALDH1A1MAPTCSF1RSMN1; SMN2
SCHEMBL8287165 0.83 HPGD (0.39) ALDH1A1CSF1RMAPK10KDM4ECSNK2A1
SCHEMBL8287801 0.83 ALDH1A2 (0.37) ALDH1A2ALDH1A1ALDH1A3MAPTCDK4
SCHEMBL8287382 0.79 PDE11A (0.43) RIPK1ALDH1A2ALDH1A1ALDH1A3MAPT
SCHEMBL8287383 0.77 PDE11A (0.41) RIPK1ALDH1A2ALDH1A1ALDH1A3CSF1R
SCHEMBL8287859 0.77 PDE11A (0.47) LMNACDK2ALDH1A1KDM4EPIM1
SCHEMBL8287141 0.76 PIK3CA (0.38) ALDH1A2ALDH1A1ALDH1A3MAPTCDK4
SCHEMBL8286378 0.75 PDE11A (0.49) LMNARIPK1CDK2CCNA2MAPT
SCHEMBL8287373 0.75 PDE11A (0.40) RIPK1ALDH1A2ALDH1A1ALDH1A3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed